MENLO PARK, Calif., Oct. 22, 2024 (GLOBE NEWSWIRE) -- PacBio (PACB), a leading developer of high-quality, highly accurate genomic sequencing solutions, today announced the inclusion of the Onso ...
Collaboration will engage leading transplant clinician-scientists to study antibody-mediated rejection (AMR) and microvascular inflammation (MVI) using cellular-resolution profiling CareDx will ...
PacBio (PACB) announced the inclusion of the Onso short-read sequencing platform in the 10x Genomics (TXG) Compatible Partner Program. The 10x Genomics Compatible Partner Program recognizes ...
Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. 10x Genomics announced new ...
Collaboration will engage leading transplant clinician-scientists to study antibody-mediated rejection (AMR) and microvascular inflammation (MVI) using cellular-resolution profiling BRISBANE, Calif.-- ...
PacBio (PACB), a leading developer of high-quality, highly accurate genomic sequencing solutions, today announced the inclusion of the Onso short-read sequencing platform in the 10x Genomics ...
Insights generated from this program are intended to support future clinical diagnostic development. CareDx will leverage 10x’s Xenium spatial and Chromium Flex single cell platforms for this ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results